Evidence map›Paper›PMID 32580481›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Antiarrhythmic Effects of Melatonin and Omega-3 Are Linked with Protection of Myocardial Cx43 Topology and Suppression of Fibrosis in Catecholamine Stressed Normotensive and Hypertensive Rats.

Barbara Szeiffova Bacova, Csilla Viczenczova, Katarina Andelova, Matus Sykora, Kiranj Chaudagar, Miroslav Barancik, Michaela Adamcova, Vladimir Knezl, Tamara Egan Benova, Peter Weismann and 2 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Connexin43 Deficiency Leads to Ventricular Arrhythmias by Reprogramming Proline Metabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Barbara Szeiffova BacovaCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.ORCID 0000-0001-8394-7459
Csilla ViczenczovaCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
Katarina AndelovaCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
Matus SykoraCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.ORCID 0000-0002-0438-3956
Kiranj ChaudagarL. M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
Miroslav BarancikCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
Michaela AdamcovaDepartment of Physiology, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic.
Vladimir KnezlCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
Tamara Egan BenovaCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.
Peter WeismannFaculty of Medicine, Comenius University, 81499 Bratislava, Slovakia.
Jan SlezakCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.ORCID 0000-0002-4217-4493
Narcisa TribulovaCentre of Experimental Medicine, SAS, 84104 Bratislava, Slovakia.ORCID 0000-0002-5904-4249
Centre of Experimental Medicine of the Slovak Academy of Sciences · SKAustrian Academy of Sciences · ATB.J. Medical College · INCharles University · CZComenius University Bratislava · SK

Funding

Agentúra na Podporu Výskumu a Vývoja 18-0548, 15-0376, 15-0119EU ITMS 26230120009Programme Progres Q 40/5Vedecká Grantová Agentúra MŠVVaŠ SR a SAV 2/0002/20, 2/0158/19
6 · The paper itself

Abstract

Cardiac β-adrenergic overstimulation results in oxidative stress, hypertrophy, ischemia, lesion, and fibrosis rendering the heart vulnerable to malignant arrhythmias. We aimed to explore the anti-arrhythmic efficacy of the anti-oxidative and anti-inflammatory compounds, melatonin, and omega-3, and their mechanisms of actions in normotensive and hypertensive rats exposed to isoproterenol (ISO) induced β-adrenergic overdrive. Eight-month-old, male SHR, and Wistar rats were injected during 7 days with ISO (cumulative dose, 118 mg/kg). ISO rats were either untreated or concomitantly treated with melatonin (10 mg/kg/day) or omega-3 (Omacor, 1.68 g/kg/day) until 60 days of ISO withdrawal and compared to non-ISO controls. Findings showed that both melatonin and omega-3 increased threshold current to induce ventricular fibrillation (VF) in ISO rats regardless of the strain. Prolonged treatment with these compounds resulted in significant suppression of ISO-induced extracellular matrix alterations, as indicated by reduced areas of diffuse fibrosis and decline of hydroxyproline, collagen-1, SMAD2/3, and TGF-β1 protein levels. Importantly, the highly pro-arrhythmic ISO-induced disordered cardiomyocyte distribution of electrical coupling protein, connexin-43 (Cx43), and its remodeling (lateralization) were significantly attenuated by melatonin and omega-3 in Wistar as well as SHR hearts. In parallel, both compounds prevented the post-ISO-related increase in Cx43 variant phosphorylated at serine 368 along with PKCε, which are known to modulate Cx43 remodeling. Melatonin and omega-3 increased SOD1 or SOD2 protein levels in ISO-exposed rats of both strains. Altogether, the results indicate that anti-arrhythmic effects of melatonin and omega-3 might be attributed to the protection of myocardial Cx43 topology and suppression of fibrosis in the setting of oxidative stress induced by catecholamine overdrive in normotensive and hypertensive rats.

Indexed as

connexin-43extracellular matrixisoproterenolmelatoninomega-3 fatty acidsrat heartventricular fibrillation

Identifiers

PMID32580481
PMCPMC7346184
OpenAlexW3036032141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.